A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells

Overview of attention for article published in Frontiers in Pharmacology, January 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 9,134 followers.

A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells https://t.co/TG3mKsIYiW #pharmacology #openaccess

30 Jan 2019

Reply Repost Favourite

RT @borja_guerra: Happy 😊. Our paper on @FrontPharmacol is out! A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogen…

10 Jan 2019

Reply Repost Favourite

Enhorabuena @borja_guerra y resto de autores

09 Jan 2019

Reply Repost Favourite

Congratulations!

09 Jan 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.